Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

Trading Statement

21 Oct 2010 07:00

RNS Number : 7190U
Impellam Group plc
21 October 2010
 



Impellam Group plc

("Impellam", the "Company" or the "Group")

 

Trading Update

 

On 6 August 2010 the Company announced its unaudited interim results for the 26 weeks ended 2 July 2010 which stated that operating profit had increased to £12.5m (2009 £0.5m). Net debt had decreased by £30.4 million to £39.2 million as at 2 July 2010 as a result of significant cash generation for the period.

 

Since the interim period end, Impellam has continued to see improved operating performance consistent with the trends experienced during the first half of the year. Net debt stands at £28.5m at 1 October 2010.

 

Cheryl Jones, Chairman, commented:

 

"For the trading period following the Groups half year end, the Company has seen operating performance improvement consistent with that experienced during the first half of the year. Efficiency programs and business rationalization have continued across the Group, and the Company continues to prioritize key drivers of our plan which include leveraging our brands, further improving our process and technology environments, investing in service innovation and refining our growth strategy."

 

 

Enquiries: For any further information please contact:

Impellam Group plc

Cheryl Jones, Chairman

Andrew Burchall, Group Finance Director

Tel: 01582 692658

Tel: 01582 692658

Cenkos Securities plc (Nominated Advisor and Broker to Impellam)

Nicholas Wells

Elizabeth Bowman

Tel: 020 7397 8900

Tel: 020 7397 8900

 

 

Note to Editors:

Impellam is traded on AIM (Symbol: IPEL) and is a leading provider of staffing solutions, human capital management and outsourced people-related services with established operations in the UK, Ireland, USA, mainland Europe, Australia and New Zealand.

 

Business Segment

Staffing Sectors/Brands

Healthcare Staffing

The Group's Healthcare staffing segment comprises Medacs Healthcare (locum doctors, nursing, international recruitment and managed healthcare services) and Chrysalis Homecare (domiciliary care).

UK Staffing - Commercial

 

The Group's UK Commercial staffing segment primarily includes those brands that operate in the traditional clerical, administrative, industrial/trades and hospitality staffing markets. These principal brands include ABC Contract Services (construction and telecoms), Blue Arrow (catering, managed services, office and industrial), Carlisle Managed Solutions (managed services), Comensura (vendor neutral staffing & recruitment procurement), and Tate (office).

UK Staffing - Professional & Technical

 

The Group's UK Professional & Technical staffing segment comprises the following principal brands: Austin Benn (sales and marketing), Celsian Education (teachers and school support staff), Chadwick Nott (legal), Hewitson Walker (accounting), IRC (multi-sector staffing in Ireland), S∙COM (technical) and SRG (scientific).

US Staffing

The Group's US staffing segment operates across a wide spectrum of staffing sectors. The principal brands and their specialties include CORESTAFF Services and Leafstone (Call centre/customer care, engineering, IT, light industrial, office/clerical, professional, skilled trade and technical), Guidant Group (managed services), InfoCurrent (information/records management and library services), S∙COM (technical and telecom) and SRG Woolf (clinical research).

Support Services

The Group's Support services segment consists of several brands providing a wide range of outsourced services to clients throughout the UK. These brands include Carlisle Cleaning & Support Services (contract cleaning and facility support services), Carlisle Security (security guarding and CCTV public space surveillance), and the Recruit (retail merchandising and events).

 

- END-

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTXBLFLBBFLFBE
Date   Source Headline
11th Jan 20249:03 amRNSForm 8.5 (EPT/NON-RI) Impellam Group Plc
10th Jan 202411:05 amRNSForm 8.3 - Impellam Group PLC
5th Jan 20242:16 pmRNSForm 8.3 - Impellam Group Plc
27th Dec 20239:02 amRNSForm 8.3 - Impellam
22nd Dec 20237:00 amRNSPublication and posting of Scheme Document
19th Dec 20239:22 amRNSForm 8.5 (EPT/RI)
19th Dec 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
18th Dec 20231:41 pmRNSForm 8.3 - Impellam Group PLC
18th Dec 202311:03 amRNSForm 8.5 (EPT/RI)
18th Dec 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
15th Dec 20231:00 pmRNSForm 8.3 -Impellam Group plc
15th Dec 20237:55 amRNSForm 8.5 (EPT/RI)
15th Dec 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
14th Dec 202311:09 amRNSForm 8.3 - Impellam Group plc
14th Dec 20237:31 amRNSForm 8.5 (EPT/RI)
13th Dec 20231:49 pmRNSForm 8.3 - Impellam Group plc
13th Dec 20237:00 amRNSRecommended Acquisition
12th Dec 20234:44 pmRNSExtension of PUSU Deadline
12th Dec 202311:08 amRNSForm 8.3 - Impellam Group plc
12th Dec 20237:46 amRNSForm 8.5 (EPT/RI)
12th Dec 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
11th Dec 202312:00 pmRNSForm 8.3 - Impellam Group plc
11th Dec 202310:53 amRNSForm 8.5 (EPT/RI)
11th Dec 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
8th Dec 202312:49 pmRNSForm 8.3 - Impellam Group plc
8th Dec 202310:14 amRNSForm 8.5 (EPT/RI)
7th Dec 202312:25 pmRNSForm 8.3 - Impellam Group plc
6th Dec 202312:35 pmRNSForm 8.3 - Impellam Group plc
6th Dec 202310:49 amRNSForm 8.5 (EPT/RI)
6th Dec 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
5th Dec 20234:00 pmRNSExtension of PUSU Deadline
5th Dec 20231:13 pmRNSForm 8.3 - Impellam Group plc
5th Dec 202310:29 amRNSForm 8.5 (EPT/RI)
5th Dec 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
4th Dec 202310:30 amRNSForm 8.3 - Impellam Group plc
1st Dec 202311:55 amRNSForm 8.3 - Impellam Group plc
30th Nov 202312:13 pmRNSForm 8.3 - Impellam Group plc
30th Nov 202310:45 amRNSForm 8.5 (EPT/RI)
30th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
29th Nov 20234:43 pmRNSExtension of PUSU Deadline
29th Nov 202312:04 pmRNSForm 8.3 - Impellam Group plc
29th Nov 202311:47 amRNSForm 8.5 (EPT/RI)
29th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
28th Nov 202312:09 pmRNSForm 8.3 - Impellam Group plc
28th Nov 202311:18 amRNSForm 8.5 (EPT/RI)
28th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
27th Nov 202310:45 amRNSForm 8.3 - Impellam Group Plc
24th Nov 202311:35 amRNSForm 8.3 - Impellam Group Plc
23rd Nov 202312:29 pmRNSForm 8.3 - Impellam Group plc
22nd Nov 202311:55 amRNSForm 8.3 - Impellam Group Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.